Cite
HARVARD Citation
Kim, B. et al. (n.d.). OnabotulinumtoxinA for chronic migraine in Korea: 1-month postmarketing surveillance and phase 4 trial results. Toxicon. pp. S49-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kim, B. et al. (n.d.). OnabotulinumtoxinA for chronic migraine in Korea: 1-month postmarketing surveillance and phase 4 trial results. Toxicon. pp. S49-. [Online].